The objective of this study is to assess the efficacy and safety of a single,
kinematic-analysis-based intramuscular injection of NT 201, compared with placebo, in
moderate to marked essential tremor of the upper limb.
Phase:
Phase 2
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA